Over the past years, several lines of evidence support a therapeutic potential of Cannabis
derivatives and in particular phytocannabinoids. Δ 9-THC and cannabidiol (CBD) are the …

Specialized plant terpenoids have found fortuitous uses in medicine due to their
evolutionary and biochemical selection for biological activity in animals. However, these …

Objective To evaluate the safety and preliminary pharmacokinetics of a pharmaceutical
formulation of purified cannabidiol (CBD) in children with Dravet syndrome. Methods …

Cannabidiol (CBD) oils are low tetrahydrocannabinol products derived from Cannabis sativa
that have become very popular over the past few years. Patients report relief for a variety of …

Background Comprehensive literature reviews of historical perspectives and evidence
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …

For hundreds of years, mankind has been influencing its sleep and waking state through the
adenosinergic system. For~ 100 years now, systematic research has been performed, first …

Objective To identify potential pharmacokinetic interactions between the pharmaceutical
formulation of cannabidiol (CBD; Epidiolex) and the commonly used antiepileptic drugs …

Background: Numerous physical, psychological, and emotional benefits have been
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …

The interest in cannabis-based products for the treatment of refractory epilepsy has
skyrocketed in recent years. Marijuana and other cannabis products with high content in Δ …

The laws governing cannabis are evolving worldwide and associated with changing
patterns of use. The main psychoactive drug in cannabis is Δ 9-tetrahydrocannabinol (THC) …